Acute subdural hematomas secondary to aneurysmal subarachnoid hemorrhage confer poor prognosis: a national perspective.


Journal

Journal of neurointerventional surgery
ISSN: 1759-8486
Titre abrégé: J Neurointerv Surg
Pays: England
ID NLM: 101517079

Informations de publication

Date de publication:
May 2021
Historique:
received: 03 06 2020
revised: 10 07 2020
accepted: 10 07 2020
pubmed: 10 8 2020
medline: 9 6 2021
entrez: 10 8 2020
Statut: ppublish

Résumé

Aneurysmal ruptures typically cause subarachnoid bleeding with intraparenchymal and intraventricular extension. However, rare instances of acute aneurysmal ruptures present with concomitant, non-traumatic subdural hemorrhage (SDH). We explored the incidence and difference in outcomes of SDH with aneurysmal subarachnoid hemorrhage (aSAH) as compared with aSAH alone. Retrospective cohort study from 2012 to 2015 from the National (Nationwide) Inpatient Sample (NIS) (20% stratified sample of all hospitals in the United States). NIS database (2012 to September 2015) queried to identify all patients presenting with aSAH. From this population, the patients with concomitant SDH were identified. A total of 10 075 patients with both cerebral aneurysms and aSAH were included. Of these, 335 cases of concomitant SDH and aSAH were identified. There was no significant change in the rate of SDH in aSAH over time. SDH with aSAH patients had a mortality of 24% compared with 12% (p=0.003) in the SAH only group, and only 16% were discharged home vs 37% (p=0.003) in the SAH group. There is a 3.5% incidence of acute SDH in patients presenting with non-traumatic aSAH. Patients with SDH and aSAH have nearly double the mortality, higher rate of discharge to nursing home and rehabilitation, and a significantly lower rate of discharge to home and return to routine functioning. This information is useful in counseling and prognostication of patients with concomitant SDH and aSAH.

Sections du résumé

BACKGROUND BACKGROUND
Aneurysmal ruptures typically cause subarachnoid bleeding with intraparenchymal and intraventricular extension. However, rare instances of acute aneurysmal ruptures present with concomitant, non-traumatic subdural hemorrhage (SDH). We explored the incidence and difference in outcomes of SDH with aneurysmal subarachnoid hemorrhage (aSAH) as compared with aSAH alone.
METHODS METHODS
Retrospective cohort study from 2012 to 2015 from the National (Nationwide) Inpatient Sample (NIS) (20% stratified sample of all hospitals in the United States). NIS database (2012 to September 2015) queried to identify all patients presenting with aSAH. From this population, the patients with concomitant SDH were identified.
RESULTS RESULTS
A total of 10 075 patients with both cerebral aneurysms and aSAH were included. Of these, 335 cases of concomitant SDH and aSAH were identified. There was no significant change in the rate of SDH in aSAH over time. SDH with aSAH patients had a mortality of 24% compared with 12% (p=0.003) in the SAH only group, and only 16% were discharged home vs 37% (p=0.003) in the SAH group.
CONCLUSIONS CONCLUSIONS
There is a 3.5% incidence of acute SDH in patients presenting with non-traumatic aSAH. Patients with SDH and aSAH have nearly double the mortality, higher rate of discharge to nursing home and rehabilitation, and a significantly lower rate of discharge to home and return to routine functioning. This information is useful in counseling and prognostication of patients with concomitant SDH and aSAH.

Identifiants

pubmed: 32769111
pii: neurintsurg-2020-016470
doi: 10.1136/neurintsurg-2020-016470
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

426-429

Informations de copyright

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Gurmeen Kaur (G)

Department of Neurosurgery, Westchester Medical Center, Valhalla, New York, USA kaur.gurmeen@gmail.com.

Katarina Dakay (K)

Neurosurgery, New York Medical College, Valhalla, New York, USA.

Tolga Sursal (T)

Department of Neurosurgery, Westchester Medical Center, Valhalla, New York, USA.

Jared Pisapia (J)

Department of Neurosurgery, Westchester Medical Center, Valhalla, New York, USA.

Christian Bowers (C)

Department of Neurosurgery, Westchester Medical Center, Valhalla, New York, USA.

Simon Hanft (S)

Neurosurgery, UMDNJ Robert Wood Johnson Medical School New Brunswick, New Brunswick, New Jersey, USA.

Justin Santarelli (J)

Department of Neurosurgery, Westchester Medical Center, Valhalla, New York, USA.

Carrie Muh (C)

Department of Neurosurgery, Westchester Medical Center, Valhalla, New York, USA.

Chirag D Gandhi (CD)

Department of Neurosurgery, Westchester Medical Center, Valhalla, New York, USA.

Fawaz Al-Mufti (F)

Neurovascular Surgery, Westchester Medical Center, Valhalla, New York, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH